CTIS2024-515924-35-00招募中1 期
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after CABG - PACeS - PACeS, final 3.0
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 3,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Patients of age =18 years who undergo isolated CABG for coronary artery disease, POAF that persists for >60 minutes or is recurrent (more than one episode) within 7 days after the index CABG
排除标准
- •Clinical history of either permanent, persistent or paroxysmal atrial fibrillation, Concomitant carotid artery endarterectomy during CABG, Concomitant aortic root replacement during CABG, Concomitant surgery for AF during CABG, Liver cirrhosis or Child-Pugh Class C chronic liver disease, Pharmacologic therapy with an investigational drug or device within 30-days prior to randomization or plan to enroll patient in an investigational drug or device trial during participation in this trial, Pregnancy at the time of randomization, Unable or unwilling to provide informed consent, Unable or unwilling to comply wit the study treatment and followup, Existence of underlying disease that limits life expectancy to less than one year, Women of childbearing potential (within two years after the last spontaneous menstruation) without effective contraceptive measures (Implanon, injections, oral contraceptives, intrauterine devices, vasectomized partner) during study participation. (Participants using hormone-based preparations must be informed about possible interactions with the study medication), Any pre-existing clinical indication for long-term OAC, Participation in other interventional studies, Patients under legal supervision or guardianship, Any absolute contraindication to OAC, Planned use of post-operative dual antiplatelet therapy (DAPT), Cardiogenic shock, Major perioperative complication occurring between CABG and randomization, Concomitant mitral valve annuloplasty during CABG, Concomitant valve surgery during CABG or prior valve surgery (including aortic, mitral, tricuspid or pulmonary), Concomitant mitral valve annuloplasty during CABG
研究者
相似试验
进行中（未招募）
1 期
Preventing formation of blood clots due to atrial fibrillation, a cardiac arrhythmia that first occurred after coronary bypass surgery, with the help of anticoagulant medications.ew-Onset Post-Operative Atrial Fibrillation afterCABGMedDRA version: 20.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersEUCTR2021-005022-18-DEIcahn School of Medicine at Mount Sinai3,200
招募中
3 期
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGBleedingStrokeAtrial FibrillationNCT04045665Icahn School of Medicine at Mount Sinai3,200
尚未招募
3 期
Early Anti-Coagulation therapy in new onset atrial fibrillation after coronary artery bypass graft operation; Warfarin vs Rivaroxaban for stroke preventioPost Operative Atrial Fibrillation.I48.0Paroxysmal atrial fibrillationIRCT20200304046696N1Tehran University of Medical Sciences1,590
招募中
不适用
AnticoaguLation ONE year after ablation of atrial fibrillation in patients with Atrial Fibrillation (ALONE AF study)Diseases of the circulatory systemKCT0005142Yonsei University Health System, Severance Hospital840
进行中（未招募）
1 期
Antiplatelet therapy after successful percutaneous coronary intervention for chronically occluded coronary artery: A prospective, multicentre, randomized study comparing two durations of dual antiplatelet therapyCTIS2023-508148-23-01Assistance Publique Hopitaux De Marseille660